WA

Wailes Augustine

Director Director DIN 02564618
DIN 02564618 First appointment Feb 2004 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Feb 2004
Shareholding value Locked Premium profile

About Wailes Augustine

Data last updated:

Wailes Augustine has 22 years in corporate governance. Formerly with 1 company, such as Albatross Drugs And Biotech Private Limited. Engaged in Technology. Contributes to corporate operations.

DIN 02564618
Primary Designation Director
First Appointment 28 Feb 2004
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director28 Feb 20042003Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Albatross Drugs And Biotech Private Limited
Premium access

Shareholding and investment profile for Wailes Augustine

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Wailes Augustine

Wailes Augustine has 22 years in corporate governance. Formerly with 1 company, such as Albatross Drugs And Biotech Private Limited. Engaged in Technology. Contributes to corporate operations.

Wailes Augustine is associated with 0 companies as a director.

Wailes Augustine has expertise in Technology.

Wailes Augustine has 22 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available